Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005973
Filing Date
2025-08-18
Accepted
2025-08-18 16:20:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3201
  Complete submission text file 0001950047-25-005973.txt   4606
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Subject) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)